AKORN INC Spending and interest coverage
- R&D / revenue · 12 months: Value 5.81%; Formula and calculation Research and development expense / revenue. Period ending 2020-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.83%; Formula and calculation Share-based compensation / revenue. Period ending 2020-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2020-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 5.81% | Research and development expense / revenue. Period ending 2020-06-30. $38.56M ÷ $663.50M × 100 ≈ 5.81% |
| Stock-based compensation / revenue · 12 months | 2.83% | Share-based compensation / revenue. Period ending 2020-06-30. $18.75M ÷ $663.50M × 100 ≈ 2.83% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 38.56M USD | Research and Development Expense |
| Revenue | 663.50M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 18.75M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -338.01M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $38.56M | $663.50M | $18.75M | $-338.01M | (m) | 5.81% | 2.83% | (m) | (m) |
| 2020-03-31 | $38.60M | $721.25M | $19.99M | $-369.50M | (m) | 5.35% | 2.77% | (m) | (m) |
| 2019-12-31 | $37.50M | $682.43M | $21.28M | $-188.06M | (m) | 5.50% | 3.12% | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $41.52M | $662.94M | $20.36M | $-424.69M | (m) | 6.26% | 3.07% | (m) | (m) |
| 2019-03-31 | $43.39M | $675.83M | $20.71M | $-428.49M | (m) | 6.42% | 3.07% | (m) | (m) |
| 2018-12-31 | $47.32M | $694.02M | $21.50M | $-388.43M | (m) | 6.82% | 3.10% | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $841.04M | (m) | $-22.88M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $1.10B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.12B | (m) | $327.57M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $39.37M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $39.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $40.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $38.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $37.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $36.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $18.31M | $334.48M | $6.63M | $93.06M | (m) | 5.47% | 1.98% | (m) | (m) |
| 2013-12-31 | $19.86M | $317.71M | $7.05M | $88.20M | (m) | 6.25% | 2.22% | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | $6.48M | (m) | (m) | (m) | Reported |
| 2012-12-31 | (m) | (m) | (m) | (m) | $6.44M | (m) | (m) | (m) | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | $3.29M | (m) | (m) | (m) | Reported |
| 2011-12-31 | (m) | $136.92M | (m) | $33.27M | $2.11M | (m) | (m) | 15.77× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $6.97M | $86.41M | $2.74M | $11.27M | $0.00 | 8.07% | 3.17% | (m) | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $4.76M | $75.89M | $2.36M | $-19.51M | $0.00 | 6.28% | 3.11% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.